Thomas Anderson insider trades
Open-market stock purchases and sales by Thomas Anderson, Director at Zevra Therapeutics, Inc, from SEC Form 4 filings since Jul 23, 2014.
Track record: 67% of 3 scored buys are up 5% or more since purchase, averaging +37%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 4, 2026 | ZVRA Zevra Therapeutics, Inc | Bought (not open market) | — |